Actavis Labs Fl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?
ACTAVIS LABS FL has eighty-one approved drugs.
There are seven tentative approvals on ACTAVIS LABS FL drugs.
Drugs and US Patents for Actavis Labs Fl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl Inc | MIRTAZAPINE | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 076307-001 | Dec 17, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Labs Fl Inc | LACOSAMIDE | lacosamide | TABLET;ORAL | 204855-001 | Jan 5, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Labs Fl Inc | FENTANYL CITRATE | fentanyl citrate | TABLET;SUBLINGUAL | 207338-004 | Nov 17, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Labs Fl | ISOTRETINOIN | isotretinoin | CAPSULE;ORAL | 205063-006 | Mar 31, 2021 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.